Hyponatremia-induced osteoporosis

Joseph G Verbalis, Julianna Barsony, Yoshihisa Sugimura, Ying Tian, Douglas J Adams, Elizabeth A Carter, Helaine E Resnick, Joseph G Verbalis, Julianna Barsony, Yoshihisa Sugimura, Ying Tian, Douglas J Adams, Elizabeth A Carter, Helaine E Resnick

Abstract

There is a high prevalence of chronic hyponatremia in the elderly, frequently owing to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Recent reports have shown that even mild hyponatremia is associated with impaired gait stability and increased falls. An increased risk of falls among elderly hyponatremic patients represents a risk factor for fractures, which would be further amplified if hyponatremia also contributed metabolically to bone loss. To evaluate this possibility, we studied a rat model of SIADH and analyzed data from the Third National Health and Nutrition Examination Survey (NHANES III). In rats, dual-energy X-ray absorptiometry (DXA) analysis of excised femurs established that hyponatremia for 3 months significantly reduced bone mineral density by approximately 30% compared with normonatremic control rats. Moreover, micro-computed tomography (microCT) and histomorphometric analyses indicated that hyponatremia markedly reduced both trabecular and cortical bone via increased bone resorption and decreased bone formation. Analysis of data from adults in NHANES III by linear regression models showed that mild hyponatremia is associated with increased odds of osteoporosis (T-score -2.5 or less) at the hip [odds ratio (OR) = 2.85; 95% confidence interval (CI) 1.03-7.86; p < .01]; all models were adjusted for age, sex, race, body mass index (BMI), physical activity, history of diuretic use, history of smoking, and serum 25-hydroxyvitamin D [25(OH)D] levels. Our results represent the first demonstration that chronic hyponatremia causes a substantial reduction of bone mass. Cross-sectional human data showing that hyponatremia is associated with significantly increased odds of osteoporosis are consistent with the experimental data in rodents. Our combined results suggest that bone quality should be assessed in all patients with chronic hyponatremia.

Copyright American Society for Bone and Mineral Research.

Figures

Fig. 1
Fig. 1
BMD is decreased in chronically hyponatremic rats. (A) BMD in excised femora from normonatremic control rats (treated with DDAVP and maintained on a solid diet) and hyponatremic rats (treated with DDAVP and maintained on a liquid diet). (B) BMD in excised femora from normonatremic control rats on liquid diet alone, on solid diet and receiving vitamin D (VD), and from hyponatremic rats with and without VD treatment. Data are shown as mean ± SEM. *p < .001.
Fig. 2
Fig. 2
Bone µCT analysis of chronically hyponatremic rats. (A) Representative images from 3D µCT reconstruction of femora from normonatremic control rats without (liquid diet group, rat 7; [Na+] = 140 mmol/L) and with vitamin D (VD) treatment (solid diet group, rat 1; [Na+] = 135 mmol/L) and from hyponatremic rats without VD treatment (liquid diet + DDAVP group, rat 14; [Na+] = 114 mmol/L) and with VD treatment (liquid diet + DDAVP + VD group, rat 21; [Na+] = 122 mmol/L). (B) Bone volume/total volume, cortical thickness, trabecular number, and trabecular spacing assessed at the same site by µCT. Data are shown as mean ± SEM; *p < .01 compared with normonatremic rats.
Fig. 3
Fig. 3
Histologic analyses by von Kossa staining of 5 µm thick longitudinal sections from the undecalcified distal femora (metaphysis and epiphysis) from experiment 1. Representative images show thinning of trabecular bone (arrows) and cortical bone (arrowheads) in sections from hyponatremic rats compared with sections from normonatremic control. Bar = 1 mm.
Fig. 4
Fig. 4
(A) Histomorphometric analysis of tibia from experiment 1 reveals increase in osteoclast numbers (TRAP-positive multinucleated cells) per tissue area in chronically hyponatremic rats. Data are shown as mean ± SEM; *p < .01 comparing samples from normonatremic and hyponatremic rats. (B) Histomorphometric analysis of tibia from experiment 2 reveals increase in osteoclastic bone resorption marker (percentage of bone surface with adjacent osteoclasts) regardless of vitamin D treatment. The number of osteoclasts per bone perimeter indicated similar significant differences in samples from experiment 2 (not shown). Data are mean ± SEM; *p < .01 comparing samples from normonatremic and hyponatremic rats. (C) Representative micrographs of 5 µm thick sections from undecalcified lumbar vertebrae show osteoclasts marked by positive TRAP staining (red). Section from a normonatremic rat is from the liquid diet group, and section from a hyponatremic rat is from the liquid diet + DDAVP group. Osteoclasts are more abundant on trabecular surfaces in sections from hyponatremic rats than in sections from normonatremic rats. Bar = 200 µm.
Fig. 5
Fig. 5
Cross-sectional association between hyponatremia and the odds of osteoporosis in adults aged 50 years and older in NHANES III. Odds of osteoporosis for the total hip and femoral neck in hyponatremic relative to normonatremic adults. Osteoporosis is defined as sex-specific BMD at the hip (total and femoral neck) of 2.5 or fewer standard deviations below the mean of whites aged 20 to 29 years. Data are expressed as the adjusted odds of osteoporosis in hyponatremic relative to normonatremic participants at the two sites, with the 95% confidence interval (CI) for the estimates. Odds ratios are adjusted for age, sex, body mass index, physical activity, serum 25(OH)D3 levels (ng/mL), and diuretic use (thiazide and nonthiazide). The p values for the association of hyponatremia with osteoporosis were .043 for total hip and .003 for femoral neck.

References

    1. Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am J Med. 2006;119:S30–35.
    1. Kleinfeld M, Casimir M, Borra S. Hyponatremia as observed in a chronic disease facility. J Am Geriatr Soc. 1979;27:156–161.
    1. Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta. 2003;337:169–172.
    1. Chen LK, Lin MH, Hwang SJ, Chen TW. Hyponatremia among the institutionalized elderly in two long-term care facilities in Taipei. J Chin Med Assoc. 2006;69:115–119.
    1. Miller M, Morley JE, Rubenstein LZ. Hyponatremia in a nursing home population. J Am Geriatr Soc. 1995;43:1410–1413.
    1. Miller M, Hecker MS, Friedlander DA, Carter JM. Apparent idiopathic hyponatremia in an ambulatory geriatric population. J Am Geriatr Soc. 1996;44:404–408.
    1. Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med. 1985;102:164–168.
    1. Gross PA, Pehrisch H, Rascher W, Schomig A, Hackenthal E, Ritz E. Pathogenesis of clinical hyponatremia: observations of vasopressin and fluid intake in 100 hyponatremic medical patients. Eur J Clin Invest. 1987;17:123–129.
    1. Verbalis JG. Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab. 2003;17:471–503.
    1. Goldsmith SR, Francis GS, Cowley AW, Jr, Levine TB, Cohn JN. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol. 1983;1:1385–1390.
    1. Martin PY, Schrier RW. Pathogenesis of water and sodium retention in cirrhosis. Kidney Int Suppl. 1997;59:S43–49.
    1. Verbalis JG. Vasopressin V2 receptor antagonists. J Mol Endocrinol. 2002;29:1–9.
    1. Greenberg A, Verbalis JG. Vasopressin receptor antagonists. Kidney Int. 2006;69:2124–2130.
    1. Verbalis JG. Control of brain volume during hypoosmolality and hyperosmolality. Adv Exp Med Biol. 2006;576:113–129.
    1. Terzian C, Frye EB, Piotrowski ZH. Admission hyponatremia in the elderly: factors influencing prognosis. J Gen Intern Med. 1994;9:89–91.
    1. Oren RM. Hyponatremia in congestive heart failure. Am J Cardiol. 2005;95:2–7B.
    1. Goldberg A, Hammerman H, Petcherski S, et al. Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction. Am J Med. 2004;117:242–248.
    1. Singhi S, Dhawan A. Frequency and significance of electrolyte abnormalities in pneumonia. Indian Pediatr. 1992;29:735–740.
    1. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006;119:71–78.
    1. Bergstrom WH, Wallace WM. Bone as a sodium and potassium reservoir. J Clin Invest. 1954;33:867–873.
    1. Bergstrom WH. The relationship of sodium and potassium to carbonate in bone. J Biol Chem. 1954;206:711–715.
    1. Edelman IS, James AH, Baden H, Moore FD. Electrolyte composition of bone and the penetration of radiosodium and deuterium oxide into dog and human bone. J Clin Invest. 1954;33:122–131.
    1. Titze J, Maillet A, Lang R, et al. Long-term sodium balance in humans in a terrestrial space station simulation study. Am J Kidney Dis. 2002;40:508–516.
    1. Verbalis JG, Drutarosky MD. Adaptation to chronic hypoosmolality in rats. Kidney Int. 1988;34:351–360.
    1. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res. 1999;14:1167–1174.
    1. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595–610.
    1. Looker AC, Orwoll ES, Johnston CC, Jr, et al. Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res. 1997;12:1761–1768.
    1. Looker AC, Johnston CC, Jr, Wahner HW, et al. Prevalence of low femoral bone density in older US women from NHANES III. J Bone Miner Res. 1995;10:796–802.
    1. Murase T, Tian Y, Fang XY, Verbalis JG. Synergistic effects of nitric oxide and prostaglandins on renal escape from vasopressin-induced antidiuresis. Am J Physiol Regul Integr Comp Physiol. 2003;284:R354–362.
    1. Kaastad TS, Reikeras O, Halvorsen V, Falch JA, Obrant KJ, Nordsletten L. Vitamin D deficiency and ovariectomy reduced the strength of the femoral neck in rats. Calcif Tissue Int. 2001;69:102–108.
    1. Binkley N, Dahl DB, Engelke J, Kawahara-Baccus T, Krueger D, Colman RJ. Bone loss detection in rats using a mouse densitometer. J Bone Miner Res. 2003;18:370–375.
    1. Vanderschueren D, Van Herck E, Nijs J, Ederveen AG, de Coster R, Bouillon R. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology. 1997;138:2301–2307.
    1. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006;119:71.
    1. Gankam KF, Andres C, Sattar L, Melot C, Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. Q J Med. 2008;101:583–588.
    1. Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell. 2006;125:247–260.
    1. Erben RG, Eberle J, Stahr K, Goldberg M. Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study. J Bone Miner Res. 2000;15:1085–1098.
    1. Murata Y, Robertson KM, Jones ME, Simpson ER. Effect of estrogen deficiency in the male: the ArKO mouse model. Mol Cell Endocrinol. 2002;193:7–12.
    1. Riggs BL. Endocrine causes of age-related bone loss and osteoporosis. Novartis Found Symp. 2002;242:247–259.
    1. Riggs BL, Melton LJ., III The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995;17:505–511S.
    1. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005;115:3318–3325.
    1. Heaney RP. Role of dietary sodium in osteoporosis. J Am Coll Nutr. 2006;25:271–266S.

Source: PubMed

3
購読する